Porcilis ColiClos

RSS

vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 04/03/2019

Authorisation details

Product details
Name
Porcilis ColiClos
Agency product number
EMEA/V/C/002011
Active substance
Clostridium perfringens type C / Escherichia coli F4ab / E. coli F4ac / E. coli F5 / E. coli F6 / E. coli LT
International non-proprietary name (INN) or common name
vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AB08
Publication details
Marketing-authorisation holder
Intervet International BV
Revision
4
Date of issue of marketing authorisation valid throughout the European Union
14/06/2012
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
Netherlands

Product information

24/02/2019 Porcilis ColiClos - EMEA/V/C/002011 - IAIN/0009

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

For the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those Escherichia coli strains which express the adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P) and caused by Clostridium perfringens type C.

Assessment history

How useful was this page?

Add your rating